|
|
||||||||
IMMUNOLOGY, HEALTH AND DISEASE |


* Department of Poultry Science, Auburn University, 260 Lem Morrison Drive, Auburn, AL 36849-5416; and
USDA-ARS, Egg Safety & Quality Research Unit, Russell Research Center, 950 College Station Road, Athens, GA 30605
1 Corresponding author: fasinyo{at}auburn.edu
Development of molecular-based immunotherapeutic strategies for controlling Salmonella Typhimurium (ST) infection in poultry requires a better understanding of intestinal and cecal cytokine responses. Accordingly, an experiment was conducted to measure changes in intestinal cytokine expression when commercial source broiler chickens were challenged with a nalidixic acid-resistant ST. Ross broiler chicks were nonchallenged with ST (control treatment) or challenged by orally giving 7.8 x 106 cfu at 4 d of age (STC treatment). Each treatment consisted of 4 replicate pens with 14 chicks per pen. Expression levels of proinflammatory cytokines, interferon-
, and antiinflammatory interleukin (IL)-10 were determined at 5 and 10 d postchallenge (PC). Intestinal flushes were also collected from each treatment at 7 d PC to estimate IgA and IgG. Results showed an upregulation in IL-1β mRNA in STC chicks at 5 d PC. By 10 d PC, the expression of IL-1β was further increased and accompanied by an upregulation of IL-6 and interferon-
mRNA, whereas IL-10 mRNA expression decreased. It was concluded that ST induced an intestinal mucosal inflammatory response in commercial source broiler chicks less than 2 wk of age.
Key Words: cytokine Salmonella Typhimurium intestine commercial-type broiler chick
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |